Terminology and abbreviations | |
---|---|
Cell fusion | A process of merging two or more cells into one by merging their plasma membranes. |
Fusogen | An agent, often a protein such as SARS-CoV-2 spike, capable of fusing cellular membranes. Viral fusogens fuse the viral
envelope to the plasma membrane of the target cell and can fuse plasma membranes of adjacent cells to each other. |
Syncytium ( plural syncytia) | A multinucleated cell produced by the fusion of two or more cells. The term comes from Greek syn “together” and kytos
“box, or cell”. |
Heterokaryon | A syncytium produced from more than one cell type, say, a pneumocyte fused to an epithelial progenitor or a leukocyte. |
Homokaryon | A syncytium produced from cells of the same type, as would be the case with the fusion of two or more pneumocytes. |
Cell hybrid | Mononuclear offspring of syncytia, produced once a syncytium undergoes mitosis. For example, hybridomas are
made by fusing leukocytes with plasmacytoma cells to obtain hybrids that produce monoclonal antibodies. |
PS (phosphatidylserine) | The most abundant anionic (negatively charged) membrane lipid. In live cells, PS is actively moved to the
cytoplasmic side of plasma membrane. |
Scramblases | Proteins, such as TMEM16F, that randomize, or scramble, the asymmetric distribution of PS across
the membrane, a process known as PS externalization . |